Need: A cutting-edge biotech company was in need of quickly expand its virtual organization to…
MSC NordicsSeptember 5, 2018
Need: A rare disease company in the respiratory space was experiencing a temporary peak in…
MSC NordicsSeptember 5, 2018
Need: A tech company in the cell biology space was experiencing pressure from its shareholders…
MSC NordicsSeptember 5, 2018
Need: A large molecule focused biotech company had decided to change its target product profile…
MSC NordicsSeptember 5, 2018
Need: A leading biotech company had grown its asset portfolio into multiple indications and needed…
MSC NordicsSeptember 5, 2018
Need: An antibody-platform company wanted to explore alternative business models as a means to generate…
MSC NordicsSeptember 5, 2018
Need: A privately held biologics company in preclinical development stage company needed to build an…
MSC NordicsSeptember 5, 2018
Need: The CEO of a high-tech medical device company needed to get a detailed understanding…
MSC NordicsSeptember 5, 2018
Need: The Chairman of a service provider parent company, with a long history of non-organic…
MSC NordicsSeptember 5, 2018
Need: The COO of a small pharma company had started to receive licensing term sheets…
MSC NordicsSeptember 5, 2018
Need: The management of an oncology company with an ongoing clinical phase 2 trial needed an…
MSC NordicsSeptember 5, 2018
Need: The CEO of an infectious disease company was facing competition from a newly approved…
MSC NordicsSeptember 5, 2018
Need: The CEO of a stem cell platform company needed to create a briefing package…
MSC NordicsSeptember 5, 2018
Need: A public biotech company wanted to understand the orphan drug designations (ODDs) opportunities that existed…
MSC NordicsSeptember 5, 2018
Need: The CEO of a biotech platform technology company needed to assess the strategic fit…
MSC NordicsSeptember 5, 2018
Need: A clinical stage pharma company needed to assess it business opportunity for its first…
MSC NordicsSeptember 5, 2018
Need: The management of a public pharma company needed a high level opportunity assessment of…
MSC NordicsSeptember 5, 2018
Need: The CEO of a clinical phase 2 company needed to reposition the company’s existing…
MSC NordicsSeptember 5, 2018
Need: A public company wanted to assess its opportunity in inlicensing assets in the immune…
MSC NordicsSeptember 5, 2018
Need: The CEO of an oncology company needed to attract 100+ MSEK in venture capital…
MSC NordicsSeptember 5, 2018
Need: An emerging pharma client needed to obtain a valuation of its highly important drug…
MSC NordicsSeptember 5, 2018
